LHON diagnosis: Opening peoples’ eyes to the invisible suffering of LHON patientsMaryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as Share XLHON diagnosis: Opening peoples’ eyes to the invisible suffering of LHON patientshttps://pharmaphorum.com/views-analysis-digital/lhon-diagnosis-invisible-suffering-lhon-patients/
Patient centricity makes ethical and commercial sensePatient centricity is no longer a buzzword, it’s an essential way of conducting business that makes both ethical Share XPatient centricity makes ethical and commercial sensehttps://pharmaphorum.com/views-analysis-market-access/patient-centricity-makes-ethical-and-commercial-sense/
Engaging with HCPS: what do HCPs want from medical meetings?There has been a myriad of reasons over the past few years to safely assume the popularity and Share XEngaging with HCPS: what do HCPs want from medical meetings?https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/
Medical meetings and what HCPs wantThe healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the Share XMedical meetings and what HCPs wanthttps://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/
Thinking niche: the challenge of pharma’s focus on small patient populationsWith the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche Share XThinking niche: the challenge of pharma’s focus on small patient populationshttps://pharmaphorum.com/white-papers/thinking-niche-the-challenge-of-pharmas-focus-on-small-patient-populations/
